We are international
Donate
• about myeloma TEXT SIZE   
publications    back

Myeloma Minute
September 20, 2012
09.20.12


September 20, 2012
Share the Minute Facebook Tweet! Clinical Trials Donate to the IMF
 


Upcoming Events

Inland Valley Multiple Myeloma Support Group
Quarter Mania Extravaganza Luncheon

George Gibson Center
Upland, California
September 22, 2012



Myeloma Center Workshop at UNC/Duke
Chapel Hill, North Carolina
Friday, October 5, 2012



6th Annual Comedy Celebration Tickets on sale now
Saturday, October 27, 2012

Coach Rob's 7th Annual Benefit Bash & Golf Tournament
Orlando, Florida
October 28-29, 2012


Scottsdale Myeloma Center Workshop at the Mayo Clinic
Saturday, November 17, 2012
Myeloma Drug News: FDA Advisory Committee to Review Pomalidomide

The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) will review Celgene’s application for approval of its drug pomalidomide on November 8, the company announced this week. The FDA has set a date of February 10, 2013 for completion of the review. “Expanding the pipeline of drugs available to treat myeloma is vitally important,” said Susie Novis, IMF President and Co-Founder. “Each new drug is needed to help fill the unmet need and contribute to the steadily improving survival for myeloma patients,” said Brian G.M. Durie, M.D.,Chairman and Co-founder of the IMF. READ MORE


x
...Update on Mayo Clinic Pomalidomide Studies
Martha Q. Lacy, M.D., reports on several recent clinical studies on pomalidomide by the team at the Mayo Clinic in Rochester, Minnesota, in the latest issue of ‘Myeloma Today.’ Data from these studies, notes Dr. Lacy, will be reported at the meeting of the American Society of Hematology (ASH) in December. READ MORE

Celgene Announces New Fast-Track Program for Patients’ First Prescriptions
Celgene Pharmaceuticals has developed a new program called Fast Track for First Prescription™ to help eligible patients receive their first prescriptions for a Celgene product as quickly and efficiently as possible. A Celgene Patient Support coordinator will ensure that “all the ducks are in a row” as quickly as possible, and remove the hurdles to accessing that first cycle of medication. READ MORE

For More Than a Sound Bite, Visit the Digital Version of ‘Myeloma Today,’ Fall 2012 Issue
In the latest issue of ‘Myeloma Today’: a moving description of how two myeloma patients from across the globe came together to bring the IMF to Japan, by IMF President and Co-Founder Susie Novis; Prof. Jesus San-Miguel receives the 10th Robert A. Kyle Lifetime Achievement Award; and IMF Hotline Coordinators answer a question about Kyprolis. READ MORE

‘Living Well with Multiple Myeloma’ Teleconference Examines Acute and Chronic Pain
Register today for this important and free teleconference on a topic of concern for many patients and caregivers. Presented Thursday, September 27, at 4 pm PDT/7 pm EDT, the session will be led by Arizona Cancer Center nurse practitioner Sandra Kurtin, who will talk about managing acute and chronic pain in myeloma patients. REGISTER HERE
 
Action Alert: Help Prevent Funding Cuts to NIH, FDA and CDC
IMF is working with several coalitions in Washington, DC to prevent across-the-board budget cuts of 8.2 percent early next year to NIH, FDA and CDC health programs. We need your help! Find out how you can contact your elected officials NOW to tell them you support a balanced approach to deficit reduction. TAKE ACTION

x

Join Our Mailing List
 
 

 

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles